Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Insulin Formulations: Types and Delivery01:27

Insulin Formulations: Types and Delivery

160
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
160
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

137
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
137
Drug Dosage Regimen: Overview01:15

Drug Dosage Regimen: Overview

3.4K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.4K
Dosage Regimen: Fixed Dose01:01

Dosage Regimen: Fixed Dose

1.8K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
1.8K
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

45.5K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
45.5K
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

256
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
256

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Leveraging Clinical Decision Support in Dental Settings to Bridge HIV Testing Gaps and Contribute to Ending the Epidemic.

ACI open·2026
Same author

Lignes directrices de pratique clinique n° 468 : Prise en charge clinique de l'endométriose.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC·2026
Same author

Guideline No. 468: Clinical Management of Endometriosis.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC·2026
Same author

MECP2-Associated Rett Syndrome Without Developmental Regression-A Case Series.

Journal of child neurology·2026
Same author

A rare intersection: Oral carcinoma cuniculatum in the context of Down syndrome.

Journal of oral and maxillofacial pathology : JOMFP·2026
Same author

First report of an inherited MYCBP2 neurodevelopmental disorder: review of proband and parent presentation.

Neurogenetics·2026

Related Experiment Video

Updated: May 24, 2025

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

2.3K

A Universal Approach to Educating Patients with HIV about Long-Acting Injectable Treatment for HIV.

Bijou Hunt1, Alice Pham2,3, Nancy Glick2

  • 1Sinai Infectious Disease Center, Sinai Chicago, Chicago, IL, USA. bijou.hunt@sinai.org.

AIDS and Behavior
|March 3, 2025
PubMed
Summary

Universal education on long-acting injectable antiretroviral treatment (LAI ART) increases patient awareness and interest, promoting equitable access to innovative HIV care. This approach ensures more people with HIV learn about and consider LAI ART options.

Keywords:
EquityHIVLong-acting injectablesTreatment

More Related Videos

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

18.4K
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

17.8K

Related Experiment Videos

Last Updated: May 24, 2025

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

2.3K
An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

18.4K
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

17.8K

Area of Science:

  • Infectious Diseases
  • Pharmacology
  • Public Health

Background:

  • Long-acting injectable antiretroviral treatment (LAI ART) offers transformative potential for HIV care and reducing health inequities.
  • Equitable rollout of LAI ART is crucial to prevent exacerbating existing health disparities.
  • Universal education is proposed as a strategy to ensure equitable access to LAI ART.

Purpose of the Study:

  • To delineate a process for universal LAI ART education for people with HIV (PWH) at an urban clinic.
  • To compare outcomes of universal versus selective education models regarding patient awareness and interest in LAI ART.
  • To document patient demographics (race/ethnicity, sex, age) related to LAI ART education and interest.

Main Methods:

  • A comparative study of selective versus universal education models for injectable cabotegravir-rilpivirine (iCAB/RPV).
  • Data collection on the proportion of patients educated and interested in LAI ART, disaggregated by demographics.
  • Statistical analysis using Chi-sq test to compare proportions between education models.

Main Results:

  • Universal education significantly increased the proportion of PWH educated about iCAB/RPV and their interest in LAI ART.
  • Demographic differences in education and interest observed in the selective model were diminished with universal education.
  • Common reasons for disinterest (fear of injections, visit frequency, satisfaction with oral ART) were consistent across both models.

Conclusions:

  • A universal education approach effectively supports equitable rollout of LAI ART.
  • The majority of PWH express interest in learning more about LAI ART.
  • Programmatic data suggests universal education is a viable strategy to enhance LAI ART adoption and reduce disparities.